Related Experiment Video
Updated: Jan 17, 2026
Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis
Francis Y He1,2, Adrienne Boire2,3
1Neuroscience Program, Graduate School of Biomedical Science, Weill Cornell Medicine, New York, USA.
Abstract:
Medulloblastoma (MB) is the most common malignant tumor in the central nervous system in childhood and regularly metastasizes to the leptomeninges following radiation therapy. Using patient-derived medulloblastoma models and genetically engineered mouse models, Nör et al. observed enhanced inflammation and infiltration of myeloid cells within the brain following irradiation. The authors identified inflammatory cytokines and the resulting breakdown of blood-brain barriers as the main culprits of MB leptomeningeal metastasis. This study demonstrated that targeting inflammation through the use of dexamethasone effectively reduced systemic inflammatory cytokines and the resulting radiation-induced leptomeningeal metastasis.
Insights
Radiation therapy can worsen medulloblastoma (MB) metastasis by increasing brain inflammation. Dexamethasone reduced inflammation and metastasis in preclinical models, offering a potential therapeutic strategy for childhood brain tumors.
Area of Science:
- Neuro-oncology
- Cancer research
- Inflammation biology
Background:
- Medulloblastoma (MB) is a primary malignant brain tumor in children.
- Leptomeningeal metastasis is a common and serious complication of MB, often occurring after radiation therapy.
- Radiation can induce inflammation and myeloid cell infiltration in the brain, potentially promoting metastasis.
Purpose of the Study:
- To investigate the mechanisms by which radiation therapy contributes to medulloblastoma leptomeningeal metastasis.
- To evaluate the efficacy of targeting inflammation as a therapeutic strategy against radiation-induced MB metastasis.
Main Methods:
- Utilized patient-derived medulloblastoma models and genetically engineered mouse models.
- Analyzed inflammatory responses and myeloid cell infiltration in the brain post-irradiation.
- Assessed the impact of dexamethasone on inflammatory cytokines and leptomeningeal metastasis.
Main Results:
- Irradiation led to enhanced brain inflammation and myeloid cell infiltration.
- Inflammatory cytokines and blood-brain barrier disruption were identified as key drivers of metastasis.
- Dexamethasone treatment effectively reduced systemic inflammatory cytokines and radiation-induced leptomeningeal metastasis.
Conclusions:
- Inflammation and blood-brain barrier breakdown are critical factors in radiation-induced medulloblastoma leptomeningeal metastasis.
- Targeting inflammation with dexamethasone shows promise in preventing or reducing metastasis in preclinical models.
- These findings suggest a potential therapeutic approach to mitigate a severe complication of childhood brain tumor treatment.
